The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Malalkree Meztihn
Country: Puerto Rico
Language: English (Spanish)
Genre: Education
Published (Last): 11 January 2018
Pages: 423
PDF File Size: 12.89 Mb
ePub File Size: 20.23 Mb
ISBN: 327-6-90794-425-6
Downloads: 45913
Price: Free* [*Free Regsitration Required]
Uploader: Faebei

This study for,ulation conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling emulgle The influence of the type of the gelling agent and the concentration of both the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design.

The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability. Commercially available CHL topical powder was used for comparison. All the prepared emulgels showed acceptable physical properties concerning color, homogeneity, consistency, spreadability, and pH value.


Foemulation also exhibited higher drug release and antifungal activity than the CHL powder. It was found that the emulsifying agent concentration had the most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

The drug release from all the emulgels was found to follow diffusion-controlled mechanism.

Optimization of chlorphenesin emulgel formulation

Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy. Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months.

As a forumlation conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and antifungal activity.

National Center for Biotechnology InformationU.

Published online Sep 1. Author information Article notes Copyright and License information Disclaimer.

Received Dec 31; Formulayion May This article has been cited by other articles in PMC. Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: The Complete Drug Reference. The Pharmaceutical Press; Swarbrick J, Fornulation JC, editors. Encyclopedia of Pharmaceutical Technology.


Marcel Dekker Inc; The Theory and Practice of Industrial Pharmacy. Lea and Febiger; Formulation and stability of chloramphenicol gel and emulgel.

Optimization of chlorphenesin emulgel formulation

Preparation of an emulgel for treatment of formulatipn ulcer on the basis of carbomers. Formulation and evaluation of topical preparations containing phenol and local vesicants. Az J Pharm Sci.

emulel Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium. Blackwell Scientific Publications; Transdermal controlled release systems. Medical Applications of Controlled Release.

A study of shear and compression deformations on hydrophilic gels of tretinoin. Bioavailability of salbutamol sulphate from different suppository formulations.

Egypt J Pharm Sci. Analysis of data on the medicament release from ointments.

Support Center Support Center. Please review our privacy policy.